Traveling Neuroscience Fellowship Program

Training the next generation of neuroscientists

20170112, Thursday, January 12, 2017, Boston, MA, USA, Brigham and Women's Hospital Institute for the Neurosciences launch imagery withing The Building for Transformative Medicine on Thursday January 12, 2017.  Background: "The BWH Institute for the Neurosciences is at the heart of a new hospital-wide approach to understanding and helping all patients with nervous system disorders." - background

( lightchaser photography © 2017 )

The goal of the PIN Traveling Fellowship Program is to support the career development of exceptional early-stage researchers in any area of basic or clinical neuroscience, by enabling them to travel to a collaborating institution and gain access to expertise and resources that are not otherwise available to them.


This program is targeted to junior investigators at BWH, including postdoctoral research fellows, clinical fellows and instructors.


The fellowship provides up to $45,000 in funding over a two-year period, which may be spent on travel costs to a collaborating institution, plus associated research expenses including a laptop computer and/or travel to scientific conferences. The fellowship program also provides access to potential mentors, collaborators, colleagues and resources of the BWH neuroscience community.


This is a competitive program, with applications reviewed by an expert panel of senior faculty members at BWH.


2019 Traveling Fellow:


Nagendran Ramalingam, PhD (Department of Neurology)

The role of alpha synuclein tetramerization at the synapse


Dr. Ramalingan is a research fellow in the lab of Professor Ulf Dettmer in the Department of Neurology. He is studying the pathophysiology of Parkinson’s Disease, which is characterized by the accumulation in the brain of deposits containing the protein alpha-synuclein.  During his fellowship, Dr. Ramalingan will work with collaborators at UCSF to understand the normal function of alpha-synuclein and how it is disrupted in Parkinson’s Disease.

2017 Traveling Fellows:


Korneel Grauwet, PhD (Department of Neurosurgery)

Harnessing ‘smart’ viruses to treat brain cancer


Dr. Grauwet is currently a postdoc in the lab of Professor Nino Chiocca, MD, chair of  the Department of Neurosurgery at BWH. The goal of Dr. Grauwet’s project is to develop a viral ‘gene therapy’ for glioblastoma, a class of brain tumor that is among the most intractable of all cancers. His plan is to develop a virus that will infect tumor cells, causing them to be attacked by the body’s own immune system.


Lillian Matthews, PhD (Department of Pediatric Newborn Medicine)

Improving neonatal neuroimaging techniques in preterm babies


Dr. Matthews is a research scientist in the lab of Professor Terrie Inder, MD, chair of the Department of Pediatric Newborn Medicine at BWH. Dr. Matthews is using MRI to study the brains of young babies, and to develop methods that will enable studies of the developing brain and understand its vulnerability to injury and stress (for example in pre-term infants).


Michael Wheeler, PhD (Department of Neurology)

Detecting genetic mechanisms in multiple sclerosis


Dr. Wheeler is a postdoc in the lab of Professor Francisco Quintana in the BWH Department of Neurology. Dr. Wheeler is studying the mechanisms underlying multiple sclerosis (MS), particularly the later, progressive stage of the disease, which is currently poorly understood and difficult to treat. Dr. Wheeler is studying gene expression in a class of glial cells known as astrocytes, which are thought to contribute to inflammation of the brain during late stage MS.


Chun-I Wu, PhD (Department of Neurology)

Identifying causative genes in Alzheimer’s disease


Dr. Wu is a postdoc in lab of Professor Tracy Young-Pearse, PhD, professor of neurology and an expert on stem cell models of neurological disease. The focus of Dr. Wu’s project is to study Down Syndrome, a genetic condition in which individuals have a greatly increased risk of developing Alzheimer’s disease (AD). Dr Wu is using stem cell models and CRISPR genome editing to understand the genetic causes of AD in these individuals.




Questions about this program may be directed to:


Charles Jennings, PhD

Executive Director, Program for Interdisciplinary Neuroscience